RaySearch Laboratories AB: Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray's online adaptive capabilities
RaySearch (STO: RAY B) and Accuray (NASDAQ: ARAY) agreed to expand their collaboration to accelerate online adaptive radiation therapy. Accuray will purchase RayStation licenses worth $8M, recognized as revenue in 2026. The partnership combines Accuray's platforms with RaySearch's software for personalized treatments.
How this was made
The 30-second read
Why it matters
The collaboration could accelerate adoption of adaptive therapy, improving clinical workflow and creating a new revenue stream for both firms.
Market read
A modest $8 M deal that signals strategic alignment in the oncology tech space, with limited immediate price impact.
What to watch
Potential future revenue from expanded license sales and cross‑selling to existing RaySearch customers.
Background
Accuray and RaySearch are partnering to integrate RayStation planning software with Accuray's Radixact and future CyberKnife platforms for online adaptive radiation therapy.
Ticker impact
Accuray announced a definitive agreement to purchase RayStation licenses worth $8 million, creating a new revenue stream in Q3‑Q4 2026.
Limited upside; price may edge higher on the news but unlikely to move sharply.
The $8 M deal is small relative to Accuray's revenue, but it signals progress on online adaptive therapy, a strategic priority.
Market effects
Highlights growing demand for adaptive radiation therapy software in the med‑tech sector.
Swedish‑based RaySearch gains exposure; U.S. oncology equipment market sees incremental collaboration.
Modest; reinforces trend of software‑hardware integration in cancer treatment worldwide.
Counterpoint
The $8 M contract is too small to materially affect Accuray's valuation; investors may overlook it.
Key entities
- CompanyAccuray Incorporated
U.S. medical device maker developing radiation therapy platforms.
- CompanyRaySearch Laboratories AB
Swedish developer of oncology treatment planning software.




